BLIS K12
Natural health product licensed in Canada
- Other names
- Advanced Blis, Blis Breath, Blis K12 Oral Care, Blis Lozenge, Blis Probiotic, Blis Ultra, Blis-Breath, Blis-ful Breath, Breath Biotics, Breath proBiotic, Oral Blis, Total Blis
- Licence holder
- Advanced Orthomolecular Research Inc.
- NPN or DIN-HM
- 80066378
- Status
- Active licence
- Licence date
- 13 January 2016
- Revision date
- 29 July 2019
- Form
- Pastille
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Streptococcus salivarius Source : K12 | 1 Milliards d'UFC | Not calculated |
| Streptococcus salivarius Source : Cellule entière | 1 Milliards d'UFC | Not calculated |
Non-medicinal ingredients
Saveur de wintergreen, Isomalt, Extrait de fruit de monk, Palmitate d'ascorbyle, Sucrose, Lactitol, Glucose, Saveur de menthe, Poudre d'Oryza Sativa (Riz), Gomme arabique, Hyprolose, Eau, Saveur de menthe poivrée, Sodium Stearyl Fumarate, Amidon de maïs modifié, Trehalose, Maltodextrine, Saveur, Poudre d'enveloppes d'Oryza sativa (Riz)
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Pastille | minimum: 1 Tous les jours ; maximum: 4 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Promotes oral health [through the recolonization of the oral cavity]. An oral probiotic for recolonization of the oral cavity after antibiotic treatment. Following oral antimicrobial rinsing, Streptococcus salivarius K 12 supplementation helps reduce volatile sulfur compound levels (halitosis). Can help reduce the incidence of Streptococcal pharyngitis/tonsillitis (sore throat caused by pathogenic variants belonging to the Streptococcus pyogenes genus).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80066378
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2019. Photograph the packaging to check whether it has changed. Photograph the packaging